While structural symmetry is a prevailing feature of homo-oligomeric proteins, asymmetry provides unique mechanistic opportunities. We present the crystal structure of full-length TRAP1, the mitochondrial Hsp90 molecular chaperone, in a catalytically active closed state. The TRAP1 homodimer adopts a distinct, asymmetric conformation, where one protomer is reconfigured via a helix swap at the middle:C-terminal domain (MD:CTD) interface. This interface plays a critical role in client binding. Solution methods validate the asymmetry and show extension to Hsp90 homologs. Point mutations that disrupt unique contacts at each MD:CTD interface reduce catalytic activity and substrate binding and demonstrate that each protomer needs access to both conformations. Crystallographic data on a dimeric NTD:MD fragment suggests that asymmetry arises from strain induced by simultaneous NTD and CTD dimerization. The observed asymmetry provides the potential for an additional step in the ATPase cycle, allowing sequential ATP hydrolysis steps to drive both client remodeling and client release.
INTRODUCTION
Protein folding is a fundamental process, and protein misfolding can dramatically impact cellular and organismal fitness. To ensure proper folding and function, cells have evolved molecular chaperones to maintain cellular homeostasis. These proteins interact with substrates at different folding stages and act in concert throughout the maturation process (Hartl et al., 2011) .
Heat shock protein 90 (Hsp90) is a highly conserved ATPdependent chaperone essential to the folding and activation of nearly 10% of the proteome (Zhao et al., 2005) . Unlike other chaperones, Hsp90 preferentially interacts with partially folded substrate ''client'' proteins (Jakob et al., 1995) and primes them for downstream protein-protein or protein-ligand interactions (Taipale et al., 2012) . Thus, beyond initial folding, Hsp90 plays an important role throughout the functional lifetime of many clients. Client proteins vary widely in sequence, structure, size, and function, and for this reason client specificity is not well understood (Echeverría et al., 2011) . Disruption of Hsp90 activity can affect evolutionary outcomes (Lindquist, 2009 ) and has been linked to human diseases, including cancer (Whitesell and Lindquist, 2005) , vascular disease (Shah et al., 1999) , and neurodegeneration (Luo et al., 2010) .
Hsp90 functions as a homodimer with each protomer consisting of three major domains: the N-terminal domain (NTD), responsible for ATP binding and hydrolysis; the middle domain (MD) that aids in hydrolysis; and the C-terminal dimerization domain (CTD) (Figures 1A and 1B) . Crystal structures, electron microscopy (EM), and small angle X-ray scattering (SAXS) in the presence or absence of nucleotide have revealed large conformational changes at the major domain boundaries. In the absence of nucleotide, a variety of distinct open states are populated that are thought to aid in binding a diverse set of clients (Krukenberg et al., , 2009 ). The crystal structure of yeast Hsp90 (yHsp90) , along with biochemical studies (Prodromou et al., 2000) , demonstrates that NTD dimerization mediates ATP hydrolysis and is essential for function. Following ATP hydrolysis, Hsp90 transiently adopts a compact ADP-bound conformation initially observed in the bacterial Hsp90 (bHsp90) (Shiau et al., 2006) and later trapped in yHsp90 and human Hsp90 (hHsp90) (Southworth and Agard, 2008) . Together, these data establish a model for the conformational cycle of Hsp90 whereby the protomer arms undergo concerted conformational changes through rounds of ATP binding, hydrolysis, and release (Krukenberg et al., 2011) . Though hydrolysis is essential for in vivo function across Hsp90 homologs (Panaretou et al., 1998) , it remains unclear how hydrolysis is coupled to client maturation.
Most eukaryotes have four Hsp90 homologs: two in the cytosol (Hsp90a/Hsp90b) and one in both the endoplasmic reticulum (GRP94) and mitochondria (TRAP1) (Johnson, 2012) . In vitro experiments demonstrate that although the fundamental conformational states are well conserved, equilibria and kinetics are unique to each Hsp90 homolog (Southworth and Agard, 2008) , suggesting adaptation to the specific needs of clients in each cellular compartment and species. Within the eukaryotic cytosol, Hsp90 function is aided by numerous Hsp90-specific cochaperones, though only one Hsp90-specific cochaperone has been detected for the prokaryotic or organellar Hsp90s (Johnson, 2012; Liu et al., 2010) .
TRAP1 is encoded in the nucleus and was originally identified as a binding partner of tumor necrosis factor receptor 1 (Song et al., 1995) . TRAP1 has since been shown to localize primarily to the mitochondria (Felts et al., 2000) and most abundantly in the matrix (Cechetto and Gupta, 2000) . Although few TRAP1 clients have been identified, there is an emerging appreciation for the role of TRAP1 in regulating mitochondrial protein homeostasis (Altieri et al., 2012) . Specifically, TRAP1 has been implicated in critical pathways, including mitochondrial fission/fusion Protomer B (orange) is similar to the p23-stabilized yHsp90 structure, while protomer A (blue) makes distinct contacts between the MD and CTD. Residues known to bind clients in this region are shown in red. Also visible is an N-terminal extension that exchanges between protomers. Cobalt atoms (pink) help stabilize crystal contacts. (B) TRAP1 domain boundaries (left), map of the helical positions within a single protomer (right) . N-to-C-terminal progression is indicated by a transition from blue to gray. (C) Comparison of TRAP1 structure to the closed state of yHsp90 (gray) (RMSD = 3.5Å ). See also Movie S1. (Takamura et al., 2012) , mitophagy (Costa et al., 2013; Zhang et al., 2013) , and the necrotic form of cell death through regulating cyclophilin D (Kang et al., 2007 ). TRAP1 appears closely linked to cancer progression (Sciacovelli et al., 2013; Yoshida et al., 2013) and appears relevant for both familial and idiopathic forms of Parkinson's disease (Butler et al., 2012; Costa et al., 2013; Zhang et al., 2013) . These characteristics highlight a growing understanding of TRAP1's biological role and underscore its potential as a unique therapeutic target.
To better understand both shared and unique aspects of TRAP1 mechanism, we determined the crystal structure of TRAP1 at 2.3 Å resolution. The full-length mature protein was crystallized as a dimer in a closed conformation with AMPPNP, ADP-AlF 4 À , or ADP-BeF 3 À . In the absence of client or cochaperones, TRAP1 adopts an unexpected asymmetric conformation with the largest deviations at the MD:CTD interface. Complementary solutionbased methods (SAXS and dipolar electron-electron resonance [DEER] ) confirm that this asymmetric state is populated in solution, and structure-based point mutations demonstrate the functional relevance of contacts at the distinct MD:CTD interfaces. Further, in vitro experiments show conservation of asymmetry between TRAP1 homologs as well as in bHsp90. Additionally, we crystallized a truncated version of a TRAP1 dimer bound to AMPPNP but lacking the CTD. This 1.7 Å NTD:MD structure is perfectly symmetric and has implications for understanding how asymmetry is formed in the full-length dimer. Both sets of structures display an N-terminal extension that we show serves a regulatory role for ATPase activity. Finally, we propose that our TRAP1 structure depicts an important functional state with significant implications for the utilization of energy from ATP hydrolysis during client remodeling.
RESULTS
Structure of Full-Length TRAP1 in an Active Closed State High-quality diffracting crystals of the mature form of TRAP1 from zebrafish (zTRAP1) (80% identical/90% similar to human TRAP1 [hTRAP1]) diffracted to 2.3 Å ; however, initial attempts at molecular replacement with previously solved Hsp90 models (full-length and NTD, MD, or CTD domains) proved unsuccessful.
Instead, the structure was experimentally phased using selenomethionine and SAD to 3.0 Å , and native structures of TRAP1 bound to three nucleotide analogs (AMPPNP, ADP-BeF 3 À , and ADP-AlF 4 À ) were refined at a maximum resolution of 2.3 Å (Table 1) . No significant differences between the analogs were observed.
The asymmetric unit contains a single closed-state dimer, with dimerization interfaces at both the CTD and the NTD ( Figure 1A) . At 2.3 Å resolution, our model presents the highest resolution 
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picture of full-length Hsp90 catalytic machinery, showing that the nucleotide coordinating residues and catalytic water necessary for hydrolysis are positioned in a manner consistent with this being a catalytically active state. Distinguishing TRAP1 features are also visible, including the characteristic ''LXCXE'' motif in the MD (Chen et al., 2006) , which we observe to form a weak disulfide bond between C516 and C542. From sequence alignments and in comparison to other Hsp90 homologs, vertebrate TRAP1 proteins have an inserted eight-residue motif that is part of helix 19 (h19).
Comparing the TRAP1 structure to the previously solved yHsp90 closed state (stabilized by the cochaperone p23) , it is clear that, while the general architecture of the Hsp90 dimer is conserved, there are striking differences (Figure 1C) . This is best illustrated with a morph between the two structures starting with TRAP1 and transitioning to the yHsp90 structure (Movie S1 available online). In addition, an ordered 14-residue N-terminal extension significantly lengthens the previously observed b strand swap (Figures 1A, 1B and 2). In general, TRAP1 adopts a more compact conformation, shrinking the overall dimer height by $4 Å and rotating clockwise by $20 to constrict the cleft between protomers. Importantly, the major differences between the yHsp90 and TRAP1 structures arise from the nonequivalent conformations of protomers in TRAP1, illustrating striking asymmetry in the closed TRAP1 structure. Asymmetry is unlikely to be a consequence of crystal contacts, as protomer B has more substantial contacts but is most similar in conformation to the protomers from the yHsp90 structure. Motivated by the unique features of our TRAP1 structure, we investigated the functional relevance of these structural elements. The N-Terminal Extension ''Strap'' Regulates ATP Hydrolysis Previous studies with truncation mutants have implicated the N terminus of yHsp90 in regulating ATPase activity, with truncations accelerating activity (Richter et al., 2002 (Richter et al., , 2006 . These residues form an initial b strand and helix (h1) and are coupled to nucleotide binding and subsequent lid closure prior to hydrolysis. In isolated NTD structures (Li et al., 2012; Shiau et al., 2006) and an apo-NTD:MD structure (Dollins et al., 2007) , the first seven residues form b strand interactions within the NTD of the cis protomer, while in the yHSP90 closed state these elements cross over to form analogous b strand contacts with the trans protomer. TRAP1, GRP94, and cytosolic hHsp90a/b all contain an extension of the N-terminal strand between 10-50 residues long. Surprisingly, this extension is not conserved in yHsp90 or in bHsp90, to which TRAP1 is most closely related (Chen et al., 2006) . Our TRAP1 structure reveals that 14 ordered residues of N-terminal extended sequence (out of 26) make extensive trans protomer interactions to fully envelope the neighboring NTD, adding an additional 771 Å 2 of surface area to the N-terminal strand swap (Figures 1A and 2A) . This extension seems to act as a ''strap'' to further stabilize the closed state. Notably, the crystal structure of Grp94 was truncated to exclude this extension (Dollins et al., 2007) .
To test the relevance of our observed strap, we truncated the extension to match yHsp90 (Dstrap) and saw a 4-fold increase in ATPase activity relative to wild-type (WT) ( Figure 2 ). As a more conservative test, we made point mutations aimed at disrupting the H87:E157 salt bridge located at the extreme N terminus of the strap (Figures 2A and 2B ). Mutating either H87 or E157 to alanine in zTRAP1 resulted in a $3-fold increase in ATPase activity over WT ( Figure 2C) . Intriguingly, the identity of equivalent residues in the cytosolic hHsp90a are swapped, preserving the salt bridge. These data support a role for the strap in regulating the Hsp90 ATPase cycle and suggest that elaborations at the N terminus may serve to further tune the ATPase cycle for the particular demands of each Hsp90 homolog.
Novel Asymmetry in the Closed-State Dimer Unexpectedly, the two protomers from the TRAP1 homodimer have significantly different conformations resulting in a distinct closed state. Although the differences are most pronounced at the domain interfaces, asymmetry pervades the entire structure (Figure 3) . To accomplish the significant global changes between TRAP1 protomers, hinge points between domains allow for flexibility and movement. Figure 3A illustrates the differences in domain orientation within the TRAP1 dimer compared to yHsp90 . Alignments between each individual domain illustrate the large changes in domain orientation relative to the overall dimer arrangement and highlights the pronounced rotation at a hinge point between the large MD (LMD) and small MD (SMD) between h14 and h15 ( Figure 1B) , near residue 471. To compensate, the NTD and CTD counterrotate to maintain functional NTD and CTD interfaces ( Figure 3A) , likely explaining the difficulty in using molecular replacement to phase our diffraction data. The separation of the MD into LMD/SMD subdomains is consistent with previous studies predicting nucleotide-dependent flexing (Morra et al., 2012) . Interestingly, the identified break point is where Hsp90 and other GHKL family members significantly diverge, suggesting unique functions of the SMD and CTD in Hsp90 systems (Meyer et al., 2003) .
By aligning domains individually and mapping interprotomer RMSDs back to the structure of protomer B, it is evident that the individual NTDs and CTDs are similar, and the largest deviations occur at the NTD:MD interface and the MD:CTD interface ( Figure 3B ). At the NTD:MD interface, the loss of hydrogen bonds between D407:K384 and E409:R383 in protomer B leads to a shift of 4.4 Å and a deviation from symmetry ( Figure 3C ). Notably, this shift occurs in a loop within the LMD (411-422), which contains residues necessary for stabilizing an active closed state . Here protomers A and B display significantly different B factors ($40 and 60, respectively), suggesting differences in energetics of the ATP g-phosphate coordination by R417 within the LMD.
The largest deviations occur at the MD:CTD interface where the CTD amphipathic helix (h22) interacts with either h17 of protomer A (h17A) or h19 of protomer B (h19B) ( Figure 3D ). The different contacts with h22 alter which face of h22 is exposed to the dimer cleft by inducing an 8 Å translation and 87 rotation toward the MD when exchanging from h17A to h19B (Movie S2). Most importantly, this motion significantly changes the spatial arrangement of residues directly implicated in client binding in bHsp90 and yHsp90 ( Figure 1A ; Movie S2) (Genest et al., 2013) , also highlighted in the morph between yHsp90 and TRAP1 (Movie S1). These conformational changes suggest a potential use of asymmetry to influence client interactions.
Solution Based Measurements Support an Asymmetric Closed State
To confirm the observed asymmetry, we sought methods that could detect an asymmetric, closed conformation in solution. SAXS has a proven ability to determine novel solution conformations for Hsp90s and to allow for deconvolution of conformational states in a mixed population . To confirm that the observed differences could be distinguished, we overlaid theoretical P(r) curves calculated for the asymmetric TRAP1 structure; the yHsp90 crystal structure, a model of TRAP1 in the yHsp90 conformation; and two symmetric models based on our asymmetric structure (homodimers of protomers A or B; Figure S1A) .
As expected, SAXS shows a compaction from a broad apo P(r) distribution upon the addition of AMPPNP or ADP-BeF 3 À ( Figure 4A ). At this resolution the structures are nearly identical across species and ATP analogs, suggesting a well-conserved closed state. To quantitatively compare the calculated P(r) curves from our models with those obtained from experimental data, the P(r) from corresponding apo data was used in a linear combination with each closed-state model for fitting (Experimental Procedures). Fit quality was gauged using a residual R, analogous to the crystallographic R factor. Qualitatively and quantitatively, the asymmetric conformation is a much better fit to the experimental data of TRAP1 in solution (Figures 4B and S1B; Table S1 ). Fits of the experimental data using symmetric models (homodimers of protomer A and protomer B) results in inferior R values (Table S1 ), supporting the existence of closed asymmetric homodimers in solution.
DEER was used as a complementary measure of asymmetry in solution, which is capable of measuring distances between two paramagnetic centers at a range of 18-60 Å to produce a distance distribution that resolves simultaneous states within the sample (Jeschke, 2012) . For our experiment, we chose a pair spanning the MD:CTD interface within one protomer and having a predicted distance change of $14 Å ( Figure 4C ; Experimental Procedures). Native cysteine residues were removed to facilitate site-specific labeling, which did not negatively affect ATPase activity and displayed a closed-state distribution by SAXS indistinguishable from WT ( Figure S2 ). After spin-labeling, heterodimers were formed by incubating with 10-fold excess cysteine-free TRAP1. Closure was induced with ADP-BeF 3 À . The resulting DEER distribution clearly shows two distinct peaks, confirming two conformations in the closed state ( Figure 4D ). To assess the generality of the TRAP1 asymmetric state, we evaluated solution scattering for the closely related bHsp90. Using previously reported closed-state SAXS data for bHsp90 , we find that our asymmetric conformation is a much better fit than the previous symmetric closed-state model ( Figure 4B ). This analysis extends our observation of an asymmetric closed state to other Hsp90 systems. Taken together, these data support an asymmetric closed conformation that is evolutionarily conserved between bacteria and humans.
Structure-Based MD:CTD Interface Mutations Severely Impair Activity Having validated our crystallographic observations, we aimed to test the functional relevance of conformational asymmetry that either exposes or buries distinct surfaces at the MD:CTD interfaces of chemically identical protomers. These interfaces vary significantly in buried surface area (410 Å 2 for A and 1057 Å 2 for B) and bonding networks. Notably, MD:CTD interface residues N519, H521, and L522 from h17 are buried, making hydrophobic and polar interactions in protomer A that are fully exposed in protomer B (calculated using PISA) (Krissinel and Henrick, 2007) . Conversely, residues E566 and I569 make interactions in protomer B and are exposed in protomer A ( Figure 5A ). To test the functionality of each MD:CTD interface, we mutated these residues and confirmed structural integrity with circular dichroism spectroscopy of WT and mutant proteins ( Figures S3A and S3B ). Electron microscopy confirmed that the mutants could reach a closed state (Figure S3C) . To assess function, ATPase activities were measured using an enzyme-coupled assay (Leskovar et al., 2008) . The protomer A triple mutant (N519A.H521A.L522K) and protomer B double mutant (E566A.I569K) show an $80% and 75% decrease in respective activity. Single mutations (protomer A:L522K and protomer B:E566A) were additionally tested and demonstrate similarly decreased activity ( Figure 5B ; Table S2 ).
Having confirmed the relevance of our asymmetric MD:CTD interfaces from the zTRAP1 structure, we wanted to extend these observations to hTRAP1. Mapping single point mutants from zTRAP1 to hTRAP1 (L507K and E551A), we observed an equivalent drop in ATPase activity ( Figure 5B ; Table S2 ), demonstrating conservation of both MD:CTD interfaces across homologs. Importantly, we find that the severity of mutations decrease with less disruptive substitutions (L507S), as well as when moving away from the interface (V555S) ( Table S2) . Not all mutations in the MD:CTD region are deleterious: C501A and C527A actually increase the ATPase rate by $2-fold ( Figure S2B ; Table S2 ). The mutant data supports our structural observations and demonstrates that both observed MD:CTD interfaces are functional for ATPase activity.
While the mutant homodimers can form a closed state, albeit with greater difficulty (Figure S4B ), they are severely impaired in their ATPase activity. To test whether simply forming an asymmetric dimer can restore the activity, we mixed the MD:CTD interface mutants at different ratios (1:3, 1:1 and 3:1) to form heterodimers ( Figure S3D ). Heterodimer formation failed to restore ATPase activity, suggesting that each dimer must be able to access both conformations in order to efficiently hydrolyze ATP.
To probe the function of the MD:CTD interfaces for client interactions, we tested the ability of WT and MD:CTD interface mutations to interact with a previously reported model substrate (D131D) . Consistent with these studies, the addition of WT D131D accelerates the ATPase of WT hTRAP1; however, no acceleration was observed for the mutants (Figure S5A ). The lack of mutant acceleration for both mutants is consistent with the requirement to access both conformations for proper progression of the ATP cycle. To measure binding, we used D19C D131D (Gillespie and Shortle, 1997) labeled with IAEDANS and measured binding by fluorescence polarization anisotropy (Experimental Procedures). Preclosed WT hTRAP1 bound with a K d of $9 mM, while the mutant designed to disrupt the interface observed in protomer A (L507K) somewhat compromised binding (K d $35 mM), whereas no binding could be detected above background for the protomer B disrupting mutation (E551A) ( Figure S5B ). These results demonstrate that conformational asymmetry is connected to functional asymmetry for client binding and supports a preferential interaction of D131D with the B interface in which the binding residues are in closer juxtaposition (Figure 1 ; Movie S2). Together, these data establish the conservation of structural and functional importance of two distinct protomer conformations within a closed state.
Loss of CTD Restores Homodimer Symmetry
Considering that the protomer arms are chemically identical, we questioned how the asymmetric conformation is formed. Fortuitously, crystal trials with full-length zTRAP1 mutated at the MD:CTD interface and in the presence of AMPPNP resulted in a distinct crystal form with higher symmetry and smaller unit cell (Table 1 ). The structure was solved by molecular replacement and refined to a resolution of 1.75 Å . The asymmetric unit contained a single protomer ending at D568 and lacking a CTD. Here, NTD dimerization is preserved by the perfect 2-fold symmetry axis in the crystal lattice (Figure 6A) . Given that the full-length protein was used to produce crystals, we reasoned the protein was locked in a closed and (B) SAXS curves of closed-state hTRAP1, zTRAP1 from (A), and bHsp90 from Krukenberg et al. (2009) . fit using a linear combination of apo data and theoretical scattering for the zTRAP1 crystal structure (asymmetric) or a closed-state model of zTRAP1 in the yHsp90 conformation (symmetric). Residuals below clearly show that asymmetric structure is best fit. See also Table S1 and Figure S1 . NTD-dimerized state via the straps, proteolyzed within the drop, and subsequently crystallized. This was confirmed by dissolving the crystals used to generate diffraction data ( Figure S6 ).
The NTD:NTD interface in this structure is very similar to that in full-length TRAP1, and the lid remains disordered between residues 203-205 despite the lower overall B factors and higher resolution. Importantly, by removing constraints resulting from CTD dimerization, the TRAP1 NTD:MD dimer is able to adopt a symmetric configuration and rotates outward by 10.5
, pivoting from the NTD:MD interface. This movement results in a maximum change of $10 Å , measured at the SMD (Figures 6B  and S7 ; Movie S3). This dimeric NTD:MD structure suggests that the simultaneous dimerization of NTDs and CTDs in the full-length protein results in a highly strained state, which is at least partially relieved by forming the asymmetric conformation. Proteolysis and removal of the CTDs allows for relaxation to a more open, symmetric state.
DISCUSSION
Here we present the first structure of the mitochondrial homolog of Hsp90, TRAP1. Perturbation of TRAP1 activity is linked to a number of human diseases, including several cancers and neurodegeneration (Butler et al., 2012; Costa et al., 2013; Kang, 2012; Zhang et al., 2013) . Though much work remains to identify particularly critical TRAP1 clients and signaling pathways, the data presented here provides a structural framework for further studies and design of TRAP1 specific therapeutic agents. Indeed, intervention with TRAP1 targeted inhibitors has already shown differential efficacy in diverse cancer models (Kang, 2012) .
While it is well appreciated that Hsp90s can dynamically sample a broad range of conformations, our full-length X-ray crystal structures bound to ATP analogs show an unexpected and previously unknown asymmetric conformation. Significant asymmetry is rarely observed in homo-oligomers (Swapna et al., 2012) but notably has been reported to be a mechanistic feature of related GHKL family members (Schoeffler and Berger, 2005) . Through the use of SAXS and DEER, we confirm the existence of asymmetry in solution and show that it is conserved from bHsp90 to hTRAP1, suggesting that the ability to adopt unique conformations between protomers occurred early in Hsp90 evolution and persisted presumably due to functional pressure in vivo. In support of this, structure-based point mutations demonstrate a functional role for asymmetry in vitro. Our dimeric NTD:MD structure suggests that simultaneous dimerization of NTD and CTD in the ATP-bound closed state results in a strained state, which is relieved by buckling at the MD:CTD interface to form the asymmetric conformation. Prote- (Ratzke et al., 2010) . As discussed below, we suggest that strain driven by ATPinduced closure and the consequent asymmetry gives rise to two conformational states having distinct functions in client maturation.
Asymmetry in the Hsp90
Mechanism Recent investigations have begun to reveal asymmetric themes in Hsp90 function. The cochaperone Aha1 stimulates the ATPase activity of Hsp90 by binding asymmetrically at the NTD:MD interface (Retzlaff et al., 2010) , while binding a single Hop cochaperone is sufficient to block ATPase activity of both protomers (Li et al., 2011) . Asymmetry in the Hsp90:Hop client loading complex has been directly observed by single-particle EM (Southworth and Agard, 2011) . Additionally, many client proteins have been shown to bind with a 1:1 stoichiometry (Motojima-Miyazaki et al., 2010; Street et al., 2011) , and wherever examined at higher resolution, structural and mutational data directly support asymmetric binding (Street et al., 2012; Vaughan et al., 2006) . Together, these studies point to the Hsp90 chaperone functioning asymmetrically in concert with various cochaperones and client proteins.
Previous Models of the Hsp90 Closed State
Prior to the TRAP1 structure presented here, the only available closed-state structure was of yHsp90 in the presence of AMPPNP and the cochaperone p23, required to obtain reasonable diffraction . Binding of p23 is important for steroid hormone receptor maturation (Hutchison et al., 1995) and has been shown to inhibit Hsp90 ATPase activity (McLaughlin et al., 2006) . In the yHsp90 structure, NTDs are dimerized with both nucleotide pockets occupied by AMPPNP and two p23 monomers bound on either side of the NTD interface. Notably, if yHsp90 were to assume the TRAP1 asymmetric conformation, only one p23 could bind, as there would be a steric clash with the second. We suggest that binding of two p23 cochaperones could be responsible for promoting the yHsp90 symmetric conformation. In support of this, NMR data has shown that binding of two p23s on hHsp90 can induce changes in the MD significantly removed from where p23 makes direct contacts (Karagö z et al., 2011) . Such changes would be expected if p23 binding were to induce a rotation in the MD toward a more symmetric state.
Extension of Asymmetry to Other Hsp90 Systems
The broader relevance of this new closed-state conformation to eukaryotic cytosolic Hsp90s is also suggested by yHsp90 data that seem better explained by the asymmetric model presented here. Previous kinetic studies have shown that T22I/F (yHsp90) mutations enhanced ATP hydrolysis while seeming sterically incompatible with the yeast closed-state model (Cunningham et al., 2008; Prodromou et al., 2000) . By contrast, these substitutions are accommodated in our TRAP1 structure, suggesting that, in the absence of p23, yHsp90 may also adopt a similar conformation during hydrolysis.
Partially buried in the yHsp90 structure, phosphorylation of S485 of yHsp90 (S526 in zTRAP1) leads to a decrease in function both in vitro and in vivo (Soroka et al., 2012) . Phosphomimetic mutations at this position showed profound functional defects, and substitution of alanine also compromised function. This serine is conserved among Hsp90s and fully exposed in protomer B of our TRAP1 structure. By contrast, phosphorylation of this residue in protomer A would disrupt the MD:CTD interface, as it is fully buried. The degree of conservation and lack of modifying enzymes in lower species indicates this position is structurally important and perhaps was later utilized as a point of regulation. Preliminary investigations directly probing asymmetry in yHsp90 have been ambiguous thus far and thus remain a future direction.
A New Model for the Hsp90 Conformational Cycle and Utilization of ATP While simple antiaggregation functionality for Hsp90s is independent of nucleotide in vitro (Jakob et al., 1995) , in vivo data clearly demonstrates the requirement for both ATP binding and hydrolysis in client maturation (Panaretou et al., 1998) . However, it remains unclear how any Hsp90 homolog utilizes the available energy from two ATPs for client maturation.
Emerging evidence from a combination of NMR, genetic screens, and mutagenesis suggests that initial client binding involves selection of a preferred conformation from an ensemble of open apo states (Genest et al., 2013; Street et al., 2012) . Particularly well characterized is the binding site highlighted in Movies S1 and S2, composed of variably exposed hydrophobic residues from both the SMD and CTD. An attractive hypothesis is that client maturation is driven by rearrangements of these binding site residues that occur upon transition to the closed state, the rate-limiting step to hydrolysis (Hessling et al., 2009; Street et al., 2011) . ATP hydrolysis would then lead transiently through the compact ADP state in which these residues are buried within Hsp90, leading to client release. The challenge then is to understand the role of ATP in this process, as affinities for Hsp90 clients are in the 1-100 mM range. Given the slow closure kinetics of Hsp90, the client would be predicted to fall off more than once during dimer closure. Therefore, it is hard to understand how 7-14 kcals of energy available from hydrolysis of ATPs would benefit a release process.
As an alternative, we propose an updated model for the chaperone cycle of Hsp90 that integrates a broad array of available information and incorporates the novel asymmetry reported here into the ATP-driven cycle of client binding, maturation, and release ( Figure 7) . Newly added are two closed states that sequentially exploit differential ATP hydrolysis by the two In the absence of nucleotide, Hsp90 exists in an equilibrium of states with varying open conformations. Upon ATP binding, the chaperone shifts to an asymmetric closed conformation that is significantly strained, leading to buckling of the MD:CTD interface (client binding residues in red; transparency for visualization). Upon hydrolysis of one ATP, strain is relieved, and the MD:CTD interface is rearranged, perhaps forming a symmetric state reminiscent of the yHsp90 conformation. This conformation can be stabilized by dual binding of cochaperone p23 (purple) at the NTD, stalling the progression of the cycle. Upon hydrolysis of the second ATP, the ADP state is transiently formed, and ADP release resets the cycle to the apo state equilibrium. Protomer arms are colored, as in Figure 1. protomers. Upon ATP binding by both protomers, the population shifts to a closed, high-energy asymmetric state, as revealed in our full-length TRAP1 structure. Unique to this model is the suggestion that hydrolysis of the first ATP leads to a change in symmetry-perhaps a transition to a symmetric closed state like the yHsp90 crystal structure. As a consequence, rearrangement of the client binding-site residues is directly coupled to ATP hydrolysis and would then be coupled to structural changes in the client. As our model implies, hydrolysis of the second ATP would cause the chaperone to transiently populate a compact ADP state, releasing clients, before releasing ADP and returning to the apo state.
While we tentatively favor a model where the first ATP hydrolysis leads to a closed state reminiscent of the previous yHsp90 structure, it is also possible that the protomer arms could flipflop between conformations or that both would assume the conformation of either protomer A or protomer B. Importantly, for each of these possibilities the MD:CTD interface must rearrange to progress through the cycle, preserving the possibility of utilizing ATP hydrolysis for doing work on a client bound to this region.
With the introduction of inherent structural asymmetry to the Hsp90 model comes a combinatorial expansion of conformations possible for interaction with clients and cochaperones. Modulating the asymmetry or the rate of forming the asymmetric state thus provides a convenient mode of regulation for overall Hsp90 function in various pathways. In support of this, several posttranslational modifications that dramatically perturb Hsp90 function are located in or near the MD:CTD interface, including the previously discussed S485 in yHsp90 (Martínez-Ruiz et al., 2005; Soroka et al., 2012) .
Despite significant sequence variation, there is strong structural conservation of Hsp90 from bacteria to humans. Thus, the ability of Hsp90 to sample an asymmetric conformation in a closed state is likely an intrinsic feature of several and potentially all Hsp90 homologs. Though future experiments are required to precisely define the progression of conformational states and how the structural asymmetry shown here is utilized for diverse Hsp90 functions, our findings provide a new hypothesis for how ATP hydrolysis could be directly coupled to client remodeling.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for further details.
Protein Production and Purification
H. sapiens and D. rerio TRAP1 were cloned into the pET151/D-TOPO expression plasmid as TEV-cleavable N-terminal 63His-tagged fusion proteins. Expression was carried out in E. coli BL21(DE3)-RIL. Cells were grown at 30 C in LB with 0.4% glucose to OD600 = 0.8 and induced with 0.4 mM IPTG at 16 C for 18 hr. TRAP1 proteins were purified by Ni-affinity chromatography, anion exchange, and size-exclusion chromatography.
Crystallization and Structure Determination Crystals were grown in 18% (w/v) PEG3350, 0.2 M sodium malonate (pH 6.6-7), and 20-42 mM hexamine cobalt mixed 1:1 with TRAP1 protein at 7-10 mg/mL. The initial NTD:MD TRAP1 crystallization hit was refined to a final condition of 0.1M sodium phosphate monobasic (pH 6.5) and 12% PEG 8000.
The initial full-length TRAP1 structures were determined with SAD phasing, and the NTD:MD structure was solved by molecular replacement.
Steady-State Hydrolysis Measurements
Steady-state hydrolysis rates were measured using the previously described ATP enzyme-coupled assay (Leskovar et al., 2008) . Assay components were mixed to a final concentration of 200 mM NADH, 400 mM PEP, 50 U/mL PK, 50 U/mL LDH, and ATP at least 10-fold over the measured K m (Table S2) . Homologs were inhibited with the Hsp90 specific inhibitors (Radicicol; data not shown).
SAXS Reaction, Data Collection, and Analysis WT TRAP1 homologs and mutant proteins were exchanged into 20 mM HEPES (pH 7.5), 50 mM KCl, 2 mM MgCl 2 , and 1 mM DTT immediately prior to the experiment. Data was collected with 75 mM protein at the ALS SIBYLS beamline 12.3.1. Data was buffer subtracted and time points averaged using scripts at 12.3.1 (ogreNew) and in-house software. The scattering data was transformed to P(r) using GNOM. Further methods were used to quantitatively compare experimental SAXS data with theoretical data.
DEER Spectroscopy
Cysteine-free hTRAP1 allowed for site specific labeling with maleimide-functionalized MSL and purified as above. Postlabeling, heterodimers were formed with 10:1 (cysteine-free WT:probe), and 2 mM ADP-BeF was added to induce closure as with SAXS measurements. Four-pulse DEER data were collected using a Bruker ELEXSYS E580 spectrometer at 34 GHz equipped with a SuperQ-FT pulse Q-band system with a 10 W amplifier and a 5 mm EN5107D2 resonator located at the Ohio Advanced EPR laboratory.
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